{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:07:07Z","timestamp":1793315227817,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160148"],"award-info":[{"award-number":["82160148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["lzujbky-2023-ct06"],"award-info":[{"award-number":["lzujbky-2023-ct06"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijbiomac.2026.150490","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:59:50Z","timestamp":1769155190000},"page":"150490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Targeting the WWP2-ASPP2 axis overcomes cisplatin resistance by inhibiting the mevalonate pathway in TP53-mutant bladder cancer"],"prefix":"10.1016","volume":"343","author":[{"given":"Qixiang","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longtu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150490_bb0005","first-page":"128","article-title":"Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN)","volume":"4","author":"Cao","year":"2024","journal-title":"J Natl Cancer Cent."},{"issue":"10061","key":"10.1016\/j.ijbiomac.2026.150490_bb0010","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.150490_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174136","article-title":"New insights into mechanisms of Cisplatin resistance: from tumor cell to microenvironment","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150490_bb0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/bs.ircmb.2020.01.005","article-title":"Links between cancer metabolism and cisplatin resistance","volume":"354","author":"Cocetta","year":"2020","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150490_bb0025","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.gendis.2022.08.014","article-title":"TP53bp2: roles in suppressing tumorigenesis and therapeutic opportunities","volume":"10","author":"Huo","year":"2023","journal-title":"Genes Dis."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.150490_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.407","article-title":"Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation","volume":"7","author":"Chen","year":"2016","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150490_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/jcmm.17687","article-title":"ASPP2 suppresses tumour growth and stemness characteristics in HCC by inhibiting Warburg effect via WNT\/\u03b2-catenin\/HK2 axis","volume":"27","author":"Liang","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.150490_bb0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canlet.2017.04.002","article-title":"ASPP2 suppresses invasion and TGF-\u03b21-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer","volume":"398","author":"Gen","year":"2017","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150490_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01291-7","article-title":"Integrated proteogenomic characterization of urothelial carcinoma of the bladder","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150490_bb0050","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.trecan.2020.11.008","article-title":"Targeting the Mevalonate Pathway in Cancer","volume":"7","author":"Juarez","year":"2021","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150490_bb0055","article-title":"Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling","volume":"11","author":"Zhang","year":"2024","journal-title":"Genes dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150490_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051088","article-title":"Mevalonate pathway enzyme HMGCS1 contributes to gastric cancer progression","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150490_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-2054-7","article-title":"Aspp2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma","volume":"10","author":"Liang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150490_bb0070","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cac2.70044","article-title":"Ubiquitination in cancer: mechanisms and therapeutic opportunities","volume":"45","author":"Zhu","year":"2025","journal-title":"Cancer Commun. (Lond.)"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150490_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05938-2","article-title":"UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer","volume":"14","author":"Xiao","year":"2023","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150490_bb0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41568-023-00658-3","article-title":"Translating p53-based therapies for cancer into the clinic","volume":"24","author":"Peuget","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150490_bb0085","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1172\/JCI123374","article-title":"Fbxw7 increases CCL2\/7 in CX3CR1hi macrophages to promote intestinal inflammation","volume":"129","author":"He","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.150490_bb0090","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.7150\/ijbs.98772","article-title":"SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocation","volume":"20","author":"Wu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"41","key":"10.1016\/j.ijbiomac.2026.150490_bb0095","doi-asserted-by":"crossref","first-page":"34473","DOI":"10.1074\/jbc.M503736200","article-title":"Control of ASPP2\/(53BP2L) protein levels by proteasomal degradation modulates p53 apoptotic function","volume":"280","author":"Zhu","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.150490_bb0100","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/onc.2013.149","article-title":"Siah2 regulates tight junction integrity and cell polarity through control of ASPP2 stability","volume":"33","author":"Kim","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2026.150490_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drup.2015.11.003","article-title":"Mechanisms of cisplatin resistance and targeting of cancer stem cells: adding glycosylation to the equation","volume":"24","author":"Ferreira","year":"2016","journal-title":"Drug Resist. Updat."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150490_bb0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1556\/AMicr.57.2010.4.8","article-title":"Cell type specific expression of the apoptosis stimulating protein (ASPP-2) in human tissues","volume":"57","author":"Alenzi","year":"2010","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"10.1016\/j.ijbiomac.2026.150490_bb0115","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-015-0447-5","article-title":"Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation","volume":"14","author":"Song","year":"2015","journal-title":"Mol. Cancer."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150490_bb0120","first-page":"2001","article-title":"Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K\/AKT pathway","volume":"52","author":"Wu","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.150490_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00281","article-title":"Metabolic plasticity in chemotherapy resistance","volume":"10","author":"Desbats","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.150490_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215761","article-title":"The mevalonate pathway in breast cancer biology","volume":"542","author":"G\u00f6bel","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150490_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07164-x","article-title":"Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer","volume":"20","author":"G\u00f6bel","year":"2020","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150490_bb0140","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1007\/s13277-014-2959-9","article-title":"Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation","volume":"36","author":"Greife","year":"2015","journal-title":"Tumour Biol."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.150490_bb0145","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.18632\/oncotarget.24229","article-title":"Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance","volume":"9","author":"Lee","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150490_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.11.011","article-title":"P53 represses the mevalonate pathway to mediate tumor suppression","volume":"176","author":"Moon","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150490_bb0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/0008-5472.CAN-19-0650","article-title":"Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress","volume":"80","author":"Kaymak","year":"2020","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150490_bb0160","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1128\/MCB.24.3.1341-1350.2004","article-title":"ASPP1 and ASPP2: common activators of p53 family members","volume":"24","author":"Bergamaschi","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150490_bb0165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/jcmm.12435","article-title":"ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy","volume":"19","author":"Shi","year":"2015","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150490_bb0170","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ncb2240","article-title":"Wwp2 is an E3 ubiquitin ligase for PTEN","volume":"13","author":"Maddika","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"36","key":"10.1016\/j.ijbiomac.2026.150490_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205629119","article-title":"Laptm5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway","volume":"119","author":"Wang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150490_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01050-2","article-title":"Wwp2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein","volume":"21","author":"Zou","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ijbiomac.2026.150490_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2020.10.007","article-title":"Palmitic acid negatively regulates tumor suppressor PTEN through T366 phosphorylation and protein degradation","volume":"496","author":"Bai","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150490_bb0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1756-9966-30-74","article-title":"Statin-induced apoptosis via the suppression of ERK1\/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma","volume":"30","author":"Yanae","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150490_bb0195","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1101\/gad.274167.115","article-title":"The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation","volume":"30","author":"Aylon","year":"2016","journal-title":"Genes Dev."},{"issue":"11\u201312","key":"10.1016\/j.ijbiomac.2026.150490_bb0200","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1101\/gad.321943.118","article-title":"Wwp2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks","volume":"33","author":"Caron","year":"2019","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150490_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.04.011","article-title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome","volume":"184","author":"Huttlin","year":"2021","journal-title":"Cell"},{"issue":"67","key":"10.1016\/j.ijbiomac.2026.150490_bb0210","doi-asserted-by":"crossref","first-page":"17677","DOI":"10.1002\/chem.201804169","article-title":"Discovery of Small Molecule WWP2 Ubiquitin Ligase Inhibitors","volume":"24","author":"Watt","year":"2018","journal-title":"Chem-eur j."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150490_bb0215","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2394895","article-title":"Expanding the inhibitor space of the WWP1 and WWP2 HECT E3 ligases","volume":"39","author":"Dudey","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150490_bb0220","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1158\/0008-5472.CAN-13-1954","article-title":"USP22 regulates oncogenic signaling pathways to drive lethal cancer progression","volume":"74","author":"Schrecengost","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150490_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-08221-8","article-title":"MET signaling drives acquired resistance to erdafitinib in muscle-invasive bladder cancer cells","volume":"16","author":"Makabe","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.150490_bb0230","article-title":"A multifunctional Fe-EGCG@RSL3 nanomedicine synergizes ferroptosis induction and tumor microenvironment remodeling for enhanced bladder cancer immunotherapy","volume":"8","author":"Zhang","year":"2025","journal-title":"Research (Wash. D. C.)."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150490_bb0235","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004076","article-title":"Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients na\u00efve or experienced for immune checkpoint blockade","volume":"10","author":"Gomez-Roca","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"39","key":"10.1016\/j.ijbiomac.2026.150490_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202501565","article-title":"Engineering CRISPR system-based bacterial outer membrane vesicle potentiates T cell immunity for enhanced cancer immunotherapy","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150490_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-63377-3","article-title":"Reprogramming the tumor microenvironment with c-MYC-based gene circuit platform to enhance specific cancer immunotherapy","volume":"16","author":"Zhan","year":"2025","journal-title":"Nat. Commun."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026004162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026004162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T04:13:47Z","timestamp":1770178427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026004162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S0141813026004162"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150490","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the WWP2-ASPP2 axis overcomes cisplatin resistance by inhibiting the mevalonate pathway in TP53-mutant bladder cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150490"}}